Editor’s Choice

In Case you Missed it:

Finance

Microbiome Drug Development: 2023 in review

Introduction Twenty twenty three marked a difficult year for the entire biopharmaceutical sector, with reduced funding across the field. Despite this difficulty, microbiome drug development companies became more creative and collaborative than ever, with partnership […]